BVCF logo

BVCF

Asia, Shanghai, China, Shanghai

Description

BVCF is a private equity and venture capital firm.

Investor Profile

BVCF has backed more than 7 startups, with 1 new investments in the last 12 months alone. The firm has led 3 rounds, about 43% of its total and boasts 9 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series B, Convertible Note rounds (top funding stages).
  • Majority of deals are located in United States, Iceland, Singapore.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
  • Led 1 rounds in the past year.

Stage Focus

  • Series C (29%)
  • Series B (29%)
  • Convertible Note (14%)
  • Series Unknown (14%)
  • Seed (14%)

Country Focus

  • United States (43%)
  • Iceland (14%)
  • Singapore (14%)
  • Germany (14%)
  • China (14%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Biopharma
  • Therapeutics
  • Electronics
  • Hospital
  • Medical Device
  • Wellness
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does BVCF frequently co-invest with?

Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
Innovation and Technology Venture Fund
Asia, Hong Kong Island, Hong Kong, Wan Chai
Co-Investments: 1
Earlybird Venture Capital
Europe, Berlin, Germany, Berlin
Co-Investments: 1
Nan Fung Life Sciences
North America, California, United States, San Francisco
Co-Investments: 1
Bay City Capital
North America, California, United States, San Francisco
Co-Investments: 1
Morningside Group
North America, Massachusetts, United States, Newton Center
Co-Investments: 2
Brunnur Ventures
Europe, Gullbringusysla, Iceland, Reykjavík
Co-Investments: 1
S
Europe, Gullbringusysla, Iceland, Reykjavík
Co-Investments: 1
Pivotal bioVenture Partners
North America, California, United States, San Francisco
Co-Investments: 2
Hyfinity Investments
Asia, Beijing, China, Beijing
Co-Investments: 1

What are some of recent deals done by BVCF?

Qiselian Biotechnology

Shanghai, Shanghai, China

Qiselian Biotechnology engages in the development of personalized cell therapy and anti-aging technologies.

BeautyBiotechnologyHealth Care
SeedApr 18, 2025
Vivalink

Santa Clara, California, United States

VivaLnk is a provider of connected healthcare solutions for in-patient and remote patient monitoring.

ElectronicsHealth CareHospitalMedicalMedical DeviceWellness
Series UnknownNov 9, 2023
Oculis

Reykjavík, Gullbringusysla, Iceland

Oculis is a clinical-stage biopharmaceutical development company focusing on ophthalmic drugs and novel drug delivery.

BiotechnologyHealth CarePharmaceutical
Series CMay 4, 2021
Amount Raised: $57,000,000
BioNTech

Mainz, Rheinland-Pfalz, Germany

BioNTech is a biopharmaceutical company that develops cancer therapeutics for infectious diseases.

BiopharmaBiotechnologyLife SciencePharmaceutical
Series BJul 9, 2019
Amount Raised: $325,000,000
Stealth BioTherapeutics

Newton, Massachusetts, United States

Stealth BioTherapeutics is a clinical-stage biotechnology company focused on genetic diseases.

BiopharmaBiotechnologyPharmaceuticalTherapeutics
Convertible NoteJun 18, 2018
Amount Raised: $100,000,000
ASLAN Pharmaceuticals

Singapore, Central Region, Singapore

ASLAN Pharmaceuticals is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies.

BiotechnologyHealth CareMedicalOncologyPharmaceutical
Series CDec 7, 2015
Amount Raised: $34,000,000
MicuRx Pharmaceuticals

Foster City, California, United States

MicuRx discovers and develops novel antimicrobials to treat drug-resistant infections and other diseases of significant unmet medical need

BiotechnologyHealth CareMedical
Series BAug 22, 2013
Amount Raised: $25,000,000